151 related articles for article (PubMed ID: 6320747)
1. [Receptor system of interferons].
Yonehara S
Gan To Kagaku Ryoho; 1984 Jan; 11(1):44-52. PubMed ID: 6320747
[TBL] [Abstract][Full Text] [Related]
2. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
[TBL] [Abstract][Full Text] [Related]
3. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
4. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
5. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
6. Internalization and degradation of receptor-bound interferon-gamma by murine macrophages. Demonstration of receptor recycling.
Celada A; Schreiber RD
J Immunol; 1987 Jul; 139(1):147-53. PubMed ID: 2953810
[TBL] [Abstract][Full Text] [Related]
7. Corticosteroids modulate the binding of recombinant interferons alpha and gamma in Namalva cells.
Diez RA; Mistchenko AS; Falcoff ET
Immunopharmacol Immunotoxicol; 1987; 9(1):115-28. PubMed ID: 2967317
[TBL] [Abstract][Full Text] [Related]
8. Single high affinity binding of interferon alpha 2 to receptors on human lymphoblastoid cells: internalization and inactivation of receptors.
Faltynek CR; McCandless S; Baglioni C
J Cell Physiol; 1985 Jun; 123(3):459-66. PubMed ID: 3157692
[TBL] [Abstract][Full Text] [Related]
9. Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells.
Dooley JS; Vergalla J; Hoofnagle JH; Zoon KC; Munson PJ; Jones EA
J Lab Clin Med; 1989 May; 113(5):623-31. PubMed ID: 2523945
[TBL] [Abstract][Full Text] [Related]
10. A large component of the antiviral activity of mouse interferon-gamma may be due to its induction of interferon-alpha.
Hughes TK; Baron S
J Biol Regul Homeost Agents; 1987; 1(1):29-32. PubMed ID: 3142215
[TBL] [Abstract][Full Text] [Related]
11. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F
J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
[TBL] [Abstract][Full Text] [Related]
13. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.
Schaber JD; Fang H; Xu J; Grimley PM; Rui H
Cancer Res; 1998 May; 58(9):1914-9. PubMed ID: 9581833
[TBL] [Abstract][Full Text] [Related]
14. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
15. Expression of IFN-alpha and IFN-gamma receptors on normal human small resting T lymphocytes and large granular lymphocytes.
Faltynek CR; Princler GL; Ortaldo JR
J Immunol; 1986 Jun; 136(11):4134-9. PubMed ID: 2939140
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor.
Means RT; Krantz SB
Exp Hematol; 1996 Feb; 24(2):204-8. PubMed ID: 8641342
[TBL] [Abstract][Full Text] [Related]
18. Biologic activities of natural and synthetic type I interferons.
Pfeffer LM
Semin Oncol; 1997 Jun; 24(3 Suppl 9):S9-63-S9-69. PubMed ID: 9208874
[TBL] [Abstract][Full Text] [Related]
19. Caveolae and clathrin-coated vesicles: two possible internalization pathways for IFN-gamma and IFN-gamma receptor.
Sadir R; Lambert A; Lortat-Jacob H; Morel G
Cytokine; 2001 Apr; 14(1):19-26. PubMed ID: 11298489
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of binding of human recombinant interferon-gamma to its receptor on human monocytes and human monocyte-like cell lines.
Finbloom DS; Hoover DL; Wahl LM
J Immunol; 1985 Jul; 135(1):300-5. PubMed ID: 3158703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
